Katalin Karikó
Ph.D.
Senior Vice President
👥Biography 个人简介
Katalin Karikó is a pioneer in mRNA technology whose discoveries enabled the development of COVID-19 mRNA vaccines and cancer immunotherapy applications. Her foundational work on nucleoside modifications to reduce immune recognition of synthetic mRNA solved a critical barrier to therapeutic mRNA development, with applications now extending to cancer vaccines and gene therapy.
Katalin Karikó是mRNA技术的先驱，她的发现促成了COVID-19 mRNA疫苗和癌症免疫治疗应用的开发。她关于核苷修饰以减少合成mRNA免疫识别的基础性工作解决了治疗性mRNA开发的关键障碍，其应用现已扩展到癌症疫苗和基因治疗。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
mRNA Modifications
Discovered that nucleoside modifications reduce inflammatory responses to mRNA.
Therapeutic mRNA
Foundational work enabling mRNA vaccines and therapeutics.
Representative Works 代表性著作
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA
Immunity (2005)
Key discovery that modified nucleosides evade innate immune sensors.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
James M. Wilson
University of Pennsylvania
Guangping Gao
University of Massachusetts Chan Medical School
Federico Mingozzi
Spark Therapeutics / University of Paris
Feng Zhang
Broad Institute / MIT
关注 Katalin Karikó 的研究动态
Follow Katalin Karikó's research updates
留下邮箱，当我们发布与 Katalin Karikó（BioNTech / University of Pennsylvania）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment